Effect of educational intervention on medication timing in Parkinson's disease: A randomized controlled trial

BMC Neurology

Volumn 7, Issue , 2007, Pages

  Grosset, Katherine A ^a   Grosset, Donald G ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; ROPINIROLE; SELEGILINE; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; DRUG USE; DYSKINESIA; FEMALE; HUMAN; INSOMNIA; INTERVENTION STUDY; MALE; MOTOR CONTROL; NAUSEA; PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SOMNOLENCE; TREATMENT RESPONSE; DRUG ADMINISTRATION; DRUG SELF ADMINISTRATION; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

AGED; ANTIPARKINSON AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT EDUCATION; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 34547437618     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-7-20     Document Type: Article

References (34)

1. Leopold NA Polansky M Hurka MR Drug adherence in Parkinson's disease Mov Disord 2004 19 513-517 10.1002/mds.20041 15133814
2. Grosset KA Bone I Grosset DG Suboptimal medication adherence in Parkinson's disease Mov Disord 2005 20 1502-1507 10.1002/mds.20602 16037924
3. Hughes DA Bagust A Haycox A Walley T Accounting for noncompliance in pharmacoeconomic evaluations Pharmacoeconomics 2001 19 1185-1197 10.2165/ 00019053-200119120-00001 11772154
4. Stocchi F Vacca L Ruggieri S Olanow CW Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: A clinical and pharmacokinetic study Arch Neurol 2005 62 905-910 10.1001/ archneur.62.6.905 15956161
5. Bezard E Brotchie JM Gross CE Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies Nat Rev Neurosci 2001 2 577-588 10.1038/35086062 11484001
6. Jenner P Pathophysiology and biochemistry of dyskinesia: Clues for the development of non-dopaminergic treatments J Neurol 2000 247 Suppl 2 II43-II50 10.1007/PL00007760 10991665
7. Grace AA Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia Neuroscience 1991 41 1-24 10.1016/0306-4522(91)90196-U 1676137
8. Onn SP West AR Grace AA Dopamine-mediated regulation of striatal neuronal and network interactions Trends Neurosci 2000 23 S48-S56 10.1016/S1471-1931(00)00020-3 11052220
9. Spencer SE Wooten GF Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation Neurology 1984 34 1105-1108 6540390
10. Melikian C White TJ Vanderplas A Dezii CM Chang E Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapy Clin Ther 2002 24 460-467 10.1016/S0149-2918(02)85047-0 11952029
11. Girvin B McDermott BJ Johnston GD A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance J Hypertens 1999 17 1627-1631 10.1097/ 00004872-199917110-00017 10608477
12. Peveler R George C Kinmonth AL Campbell M Thompson C Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: Randomised controlled trial BMJ 1999 319 612-615 28214 10473477
13. Henry A Batey RG Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: The HelP Study Am J Gastroenterol 1999 94 811-815 10.1111/j.1572-0241.1999.00856.x 10086671
14. Rosen MI Rigsby MO Salahi JT Ryan CE Cramer JA Electronic monitoring and counseling to improve medication adherence Behav Res Ther 2004 42 409-422 10.1016/S0005-7967(03)00149-9 14998735
15. Weber R Christen L Christen S Tschopp S Znoj H Schneider C Schmitt J Opravil M Gunthard HF Ledergerber B Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial Antivir Ther 2004 9 85-95 15040540
16. O'Donnell C Donohoe G Sharkey L Owens N Migone M Harries R Kinsella A Larkin C O'Callaghan E Compliance therapy: A randomised controlled trial in schizophrenia BMJ 2003 327 834 214016 14551096 10.1136/ bmj.327.7419.834
17. Becker LA Glanz K Sobel E Mossey J Zinn SL Knott KA A randomized trial of special packaging of antihypertensive medications J Fam Pract 1986 22 357-361 3958683
18. Gibb WR Accuracy in the clinical diagnosis of parkinsonian syndromes Postgrad Med J 1988 64 345-351 3059338
19. Fahn S Elton R L members of the UPDRS Development Committee Unified Parkinson's disease rating scale Recent develpoments in Parkinson's disease Florham Park,NJ, MacMillan Healthcare Information 2 1987 153-163
20. Hoehn MM Yahr MD Parkinsonism: Onset, progression and mortality Neurology 1967 17 427-442 6067254
21. Schwab RS England AC Jr. Parkinson's disease: Rehabilitation aspects Rehabil Lit 1961 22 326-336 13909632
22. Folstein M F Folstein S E McHugh P R Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 189-198 10.1016/0022-3956(75)90026-6 1202204
23. Yesavage JA Brink TL Rose TL Lum O Huang V Adey M Leirer VO Development and validation of a geriatric depression screening scale: A preliminary report J Psychiatr Res 1982 17 37-49 10.1016/0022-3956(82)90033-4 7183759
24. Jenkinson C Fitzpatrick R Peto V Greenhall R Hyman N The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score Age Ageing 1997 26 353-357 10.1093/ageing/26.5.353 9351479
25. Parkin SG Gregory RP Scott R Bain P Silburn P Hall B Boyle R Joint C Aziz TZ Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients Mov Disord 2002 17 682-692 10.1002/mds.10186 12210857
26. Fulmer TT Feldman PH Kim TS Carty B Beers M Molina M Putnam M An intervention study to enhance medication compliance in community-dwelling elderly individuals J Gerontol Nurs 1999 25 6-14 10711101
27. Hugen PW Langebeek N Burger DM Zomer B van Leusen R Schuurman R Koopmans PP Hekster YA Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring J Acquir Immune Defic Syndr 2002 30 324-334 12131570
28. Bull SA Hunkeler EM Lee JY Rowland CR Williamson TE Schwab JR Hurt SW Discontinuing or switching selective serotonin-reuptake inhibitors Ann Pharmacother 2002 36 578-584 10.1345/aph.1A254 11918502
29. Lee JY Kusek JW Greene PG Bernhard S Norris K Smith D Wilkening B Wright JT Jr. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study Am J Hypertens 1996 9 719-725 10.1016/ 0895-7061(96)00056-8 8862216
30. Haynes RB McDonald H Garg AX Montague P Interventions for helping patients to follow prescriptions for medications Cochrane Database Syst Rev 2002 CD000011 12076376
31. Cramer JA Mattson RH Prevey ML Scheyer RD Ouellette VL How often is medication taken as prescribed? A novel assessment technique JAMA 1989 261 3273-3277 10.1001/jama.261.22.3273 2716163
32. Vrijens B Belmans A Matthys K de Klerk E Lesaffre E Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin Pharmacoepidemiol Drug Saf 2006 15 115-121 10.1002/pds.1198 16342302
33. Claxton AJ Cramer J Pierce C A systematic review of the associations between dose regimens and medication compliance Clin Ther 2001 23 1296-1310 10.1016/S0149-2918(01)80109-0 11558866
34. Cramer JA Glassman M Rienzi V The relationship between poor medication compliance and seizures Epilepsy Behav 2002 3 338-342 10.1016/ S1525-5050(02)00037-9 12609331